Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Clinical Trial
  4. /
  5. Phenylbutyrate Therapy for Maple...

Phenylbutyrate Therapy for Maple Syrup Urine Disease

May 27, 2020checkorphan
Learn more about:
Maple syrup urine disease
Related Clinical Trial
Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD) Phenylbutyrate Therapy for Maple Syrup Urine Disease

Recruitment Information

Administrative Informations

Related News

  • University of Pennsylvania and Moderna’s mRNA Therapy Extends Su
  • Relief Therapeutics Announces Executive Changes
  • Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreem
  • Relief and APR Applied Pharma Research Sign and Close Definitive Agree
  • Relief Provides Update on Progress and Plans with ACER-001 for the Tre
More News

Related Clinical Trial

  • Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup
More Clinical Trial

Related

  • University of Pennsylvania and Moderna’s mRNA Therapy Extends Su
  • Relief Therapeutics Announces Executive Changes
  • Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreem
  • Relief and APR Applied Pharma Research Sign and Close Definitive Agree
  • Relief Provides Update on Progress and Plans with ACER-001 for the Tre
  • Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup
  • Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Ex
  • Maple syrup urine disease
  • Recombine
  • Sports grill goes to bat for Baby Dylan
More
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2024 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo